SEC Tracker
Get the app

Tempest Therapeutics TPST

John W. Frederick reports stock option grant

John W. Frederick (Director) reported option or other derivative trades in TPST

Form
4
Filed
Importance
Routine
  1. Stock option for 25,000 shares
  2. Exercise price of $0.74
  3. Vesting over three years
  4. Grant date Oct 13, 2026

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Tempest Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025
  2. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  3. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  4. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  5. Champions Oncology CSBR public float $29M, Oct 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.